Geriatric and Surgical Comanagement for Older Patients With Cancer: Armin Shahrokni, MD, MPH

Patients aged 75 years and older face an increased risk of mortality and postoperative events when undergoing surgical treatment for cancer. In a study recently published in JAMA Network Open, a research team led by first author Armin Shahrokni, MD, MPH, found that patients whose care was managed by both the surgical and geriatric teams experienced significantly better outcomes compared with those whose care was provided by the surgical team alone. In this interview with i3 Health, Dr. Shahrokni...
Continue reading

Geriatric Comanagement Improves Surgical Outcomes in Older Patients With Cancer

In older patients with cancer undergoing surgical treatment, collaboration between surgical and geriatric teams significantly decreases 90-day postoperative mortality. Patients aged 75 years and older face unique challenges when undergoing cancer-related surgery, including an increased risk of adverse postoperative events, a heightened risk of delirium, difficulties in recovering mobility and functional activity, and the need for appropriate care after hospital discharge. However, collaboration ...
Continue reading

​Connecting With Patients With Cancer in Spite of COVID-19: Kiri A. Cook, MD

The stress of having cancer and the physical and financial toll of treatment can be difficult for patients, even under normal circumstances. During the COVID-19 pandemic, patients face additional stressors, including not only the fear of mortality from COVID-19 but also the emotional impact of isolation. This sense of isolation can be present even in patients' cancer care, as many appointments take place through videoconferencing and telephone calls; even when in-person appointmen...
Continue reading

IVC Filter Efficacy in Patients With Cancer and Deep Vein Thrombosis: Rahul A. Sheth, MD

Patients with cancer are at substantially increased risk for deep vein thrombosis (DVT) and resulting pulmonary embolism. Together, these two forms of venous thromboembolism constitute the second leading cause of death for patients with known malignancies. The standard of care for DVT is anticoagulation, yet many patients with cancer and DVT are unable to receive anticoagulation because of the bleeding risk that it poses. In a study recently published in JAMA Internal Medicine, a team of investi...
Continue reading

In Cancer Patients With DVT, IVC Filter Reduces Pulmonary Embolism Risk

A new study finds that for patients with cancer and deep vein thrombosis (DVT), placement of an inferior vena cava (IVC) filter reduces the risk of pulmonary embolism. Venous thromboembolism (VTE) poses a substantial problem for patients with cancer: it occurs four to seven times more frequently in this population, and it is the second overall leading cause of death for patients with known malignancies. Pulmonary embolism is a potentially deadly condition that can develop as a result of VTE, and...
Continue reading

Copyright © 2020 i3 Health. All rights reserved.